Menu
Report of evaluation results to relevant stakeholders
Summary
Reporting activities will be organised as the following subtasks:
3.4.1: the annual monitoring report will describe implemented activities, achieved outputs and evaluated risks;
3.4.2: the interim report will provide assessment of project activities, examine deviations from the work plan, present results achieved thus far and SWOT, and will inform development of recommendations and/or course correction;
3.4.3: the final evaluation report will assess the progress towards objectives and impact of actions implemented thus far considering national and European levels. Conclusions and recommendations on cancer screening will be made.
This task will be led by the UWK, Austria.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
